Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
- 19 February 2005
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 66 (2-3) , 159-163
- https://doi.org/10.1016/j.antiviral.2005.01.003
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)Virology, 2004
- Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by NiclosamideAntimicrobial Agents and Chemotherapy, 2004
- Interferon-β 1a and SARS Coronavirus ReplicationEmerging Infectious Diseases, 2004
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003
- A Major Outbreak of Severe Acute Respiratory Syndrome in Hong KongNew England Journal of Medicine, 2003
- Recent progress in antiviral chemotherapy for respiratory syncytial virus infectionsExpert Opinion on Investigational Drugs, 2000
- The broad spectrum antiviral agent ribavirin inhibits capping of mRNABiochemical and Biophysical Research Communications, 1979
- Virazole (1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide; A cytostatic agentBiochemical Pharmacology, 1977
- Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin TriphosphateAntimicrobial Agents and Chemotherapy, 1977
- CONSEQUENCES OF INHIBITION OF GUANINE NUCLEOTIDE SYNTHESIS BY MYCOPHENOLIC-ACID AND VIRAZOLE1977